Glucagon and insulin have opposite effects on tissue chromium distribution in an obese mouse model

Journal of Diabetes Investigation

Volumn 4, Issue 6, 2013, Pages 528-532

  Lin, Chang ^a   Chen, Po Wen ^b   Chen, Wen Ying ^a   Sun, Chi Ching ^a   Mao, Frank Chiahung ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b NURSING AND MANAGEMENT COLLEGE   (Taiwan)

Author keywords

Chromium; Glucagon; Insulin

Indexed keywords

CHROMIUM; GLUCAGON; INSULIN; PLACEBO;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE LEVEL; CONTROLLED STUDY; LIPID DIET; LIVER LEVEL; MALE; MOUSE; MOUSE MODEL; MUSCLE LEVEL; NONHUMAN; OBESITY; PRIORITY JOURNAL; TISSUE DISTRIBUTION; TISSUE LEVEL;

EID: 84888430482     PISSN: 20401116     EISSN: 20401124     Source Type: Journal    
DOI: 10.1111/jdi.12097     Document Type: Article

References (20)

1. Pechova A, Pavlata L. Chromium as an essential nutrient: a review. Vet Med 2007; 52: 1-18.
2. Cefalu WT, Hu FB. Role of chromium in human health and in diabetes. Diabetes Care 2004; 27: 2741-2751.
3. Vincent JB. The biochemistry of chromium. J Nutr 2000; 130: 715-718.
4. Muller WA, Faloona GR, Aguilar-Parada E, et al. Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion. N Engl J Med 1970; 283: 109-115.
5. Reaven GM, Chen YD, Golay A, et al. Documentation of hyperglucagonemia throughout the day in nonobese and obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1987; 64: 106-110.
6. Johnson DG, Goebel CU, Hruby VJ, et al. Hyperglycemia of diabetic rats decreased by a glucagon receptor antagonist. Science 1982; 215: 1115-1116.
7. Qureshi SA, Rios CM, Xie D, et al. A novel glucagon receptor antagonist inhibits glucagon-mediated biological effects. Diabetes 2004; 53: 3267-3273.
8. Anderson RA. Chromium as an essential nutrient for humans. Regul Toxicol Pharmacol 1997; 26(Suppl.): S35-S41.
9. Morris BW, Griffiths H, Kemp GJ. Effect of glucose loading on concentrations of chromium in plasma and urine of healthy adults. Clin Chem 1988; 34: 1114-1116.
10. Chen WY, Chen CJ, Liu CH, et al. Chromium supplementation enhances insulin signalling in skeletal muscle of obese KK/HlJ diabetic mice. Diabetes Obes Metab 2009; 11: 293-303.
11. Nishina PM, Verstuyft J, Paigen B. Synthetic low and high fat diets for the study of atherosclerosis in the mouse. J Lipid Res 1990; 31: 859-869.
12. Polotsky VY, Li J, Punjabi NM, et al. Intermittent hypoxia increases insulin resistance in genetically obese mice. J Physiol 2003; 552: 253-264.
13. Di Bona KR, Love S, Rhodes NR, et al. Chromium is not an essential trace element for mammals: effects of a "low-chromium" diet. J Biol Inorg Chem 2011; 16: 381-390.
14. Chen G, Liu P, Pattar GR, et al. Chromium activates glucose transporter 4 trafficking and enhances insulin-stimulated glucose transport in 3T3-L1 adipocytes via a cholesterol-dependent mechanism. Mol Endocrinol 2006; 20: 857-870.
15. Chen WY, Chen CJ, Liao JW, et al. Chromium attenuates hepatic damage in a rat model of chronic cholestasis. Life Sci 2009; 84: 606-614.
16. Chen WY, Chen CJ, Liu CH, et al. Chromium attenuates high-fat diet-induced nonalcoholic fatty liver disease in KK/HlJ mice. Biochem Biophys Res Commun 2010; 397: 459-464.
17. Borguet F, Cornelis R, Lameire N. Speciation of chromium in plasma and liver tissue of endstage renal failure patients on continuous ambulatory peritoneal dialysis. Biol Trace Elem Res 1990; 26-27: 449-460.
18. Clodfelder BJ, Emamaullee J, Hepburn DD, et al. The trail of chromium(III) in vivo from the blood to the urine: the roles of transferrin and chromodulin. J Biol Inorg Chem 2001; 6: 608-617.
19. Clodfelder BJ, Vincent JB. The time-dependent transport of chromium in adult rats from the bloodstream to the urine. J Biol Inorg Chem 2005; 10: 383-393.
20. Sun Y, Ramirez J, Woski SA, et al. The binding of trivalent chromium to low-molecular-weight chromium-binding substance (LMWCr) and the transfer of chromium from transferrin and chromium picolinate to LMWCr. J Biol Inorg Chem 2000; 5: 129-136.